Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donors

Few patients with nonfavorable risk (NFR) acute leukemia and myeloid dysplasia syndrome (AL/MDS) undergo allogeneic transplantation (HCT). We assessed whether this could be improved by integrating HCT/leukemia care and the use of haploidentical donors. Of 256 consecutive patients aged <75 years w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bashey, Asad, Zhang, Xu, Morris, Lawrence E., Holland, H. K., Bachier-Rodriguez, Lizamarie, Solomon, Scott R., Solh, Melhem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393736/
https://www.ncbi.nlm.nih.gov/pubmed/36961350
http://dx.doi.org/10.1182/bloodadvances.2023009765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393736/
https://www.ncbi.nlm.nih.gov/pubmed/36961350
http://dx.doi.org/10.1182/bloodadvances.2023009765

Ejemplares similares